Combined immunosuppression for acquired hemophilia A: CyDRi is a highly effective low-toxicity regimen

Acquired hemophilia A (AHA) is a rare severe autoimmune bleeding disorder with significant morbidity and mortality. Although critical for disease control, there is no consensus for the best immunosuppressive regimen. Most authors use steroids first line, followed by other agents for steroid failures...

Descripción completa

Detalles Bibliográficos
Autores principales: Simon, Barbara, Ceglédi, Andrea, Dolgos, János, Farkas, Péter, Gaddh, Manila, Hankó, László, Horváth, Robert, Kaposi, Ambrus, Magyar, Lászlóné, Masszi, Tamás, Szederjesi, Attila, Wohner, Nikolett, Bodó, Imre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2022
Materias:
Thrombosis and Hemostasis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653022/
https://www.ncbi.nlm.nih.gov/pubmed/35930747
http://dx.doi.org/10.1182/blood.2022016873

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10653022/
https://www.ncbi.nlm.nih.gov/pubmed/35930747
http://dx.doi.org/10.1182/blood.2022016873

Ejemplares similares